Cargando…
A222 EFFECT OF CLINICAL FACTORS ON IBD TREATMENT RESPONSE: FINDINGS FROM A NOVEL SINGLE CENTER PATIENT REGISTRY
BACKGROUND: Inflammatory bowel disease (IBD), comprising both Crohn’s disease as well as ulcerative colitis, has shown heterogenous response to therapy. Over the past decades, targeted biologic therapies have become the mainstay of treatment. Even with the rapid pace of progress in this field, rough...
Autores principales: | Lavalle, C, Khanna, R, Asfaha, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991345/ http://dx.doi.org/10.1093/jcag/gwac036.222 |
Ejemplares similares
-
A86 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS HIGHER FOLLOWING LEGALIZATION OF CANNABIS IN CANADA AND IS ASSOCIATED WITH LOWER QUALITY OF LIFE
por: Iablokov, V, et al.
Publicado: (2023) -
A74 URGENCY FOR BOWEL MOVEMENTS IS A HIGHLY DISCRIMINATORY SYMPTOM FOR ACTIVE DISEASE IN PERSONS WITH IBD (THE MANITOBA LIVING WITH IBD STUDY)
por: Kulyk, A, et al.
Publicado: (2023) -
A93 IMPROVING INPATIENT ENDOSCOPY PROCEDURAL THROUGHPUT: A QUALITY IMPROVEMENT INITIATIVE AT AN ACADEMIC MEDICAL CENTER
por: Alsager, M, et al.
Publicado: (2023) -
P222: Period vs point prevalence – what is the difference?
por: Zingg, W, et al.
Publicado: (2013) -
Juvenile dermatomyositis: clinical features, laboratory findings, treatment modalities and disease course (a single center experience)
por: Kasapcopur, Ozgur, et al.
Publicado: (2014)